Eli Lilly and Company chief financial officer Joshua Smiley said in an interview with Scrip that “there are some long-term savings that we'll have as a function of realizing that there are many things that we can do virtually that we never have to do in person again” because of the COVID-19 pandemic.
That includes global meetings Lilly has internally and external medical meetings where the company would have sent 50 or 60...